References

58.Lester D. Serum cholesterol levels and suicide: a meta-

analysis. Suicide Life Threat Behav 2002; 32: 333-46.

59. Edgar PF, Hooper AJ, Poa NR, Burnett JR. Violent behavior

associated with hypocholesterolemia due to a novel APOB

gene mutation. Mol Psychiatry 2007; 12: 258-63.

60. Lalovic A, Levy E, Luheshi G, et al. Cholesterol content in

brains of suicide completers. Int J Neuropsychopharmacol

2007; 10: 159-66.

61. Muldoon MF, Manuck SB, Mendelsohn AB, Kaplan JR, Belle

SH. Cholesterol reduction and non-illness mortality: meta-

analysis of randomised clinical trials. BMJ 2001; 322: 11-5.

62. Baigent C, Keech A, Kearney PM, et al.; Cholesterol

Treatment Trialists’ (CTT) Collaborators. Efficacy and safety

of cholesterol-lowering treatment: prospective meta-

analysis of data from 90,056 participants in 14

randomised trials of statins. Lancet 2005; 366: 1267-78.

63. Golomb BA, Kane T, Dimsdale JE. Severe irritability

associated with statin cholesterol-lowering drugs. QJM